Facial injectables Market Size by Treatment, Type, End User and Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2029
9.6%
CAGR (2022-2029)
4.88 USD Bn.
Market Size
308
Report Pages
127
Market Tables
Overview
Facial injectables Market was valued US$ 4.88 Bn in 2021 and is expected to reach US$ 10.17 Bn by 2029, at CAGR of 9.6 % during forecast period of 2022 to 2029.
Facial injectable products also known as dermal Fillers. These are the products which help in facial rejuvenation. The facial injectable products are mostly used to treat the early signs of ageing such as wrinkles thereby increasing the aesthetic beauty.
To know about the Research Methodology :- Request Free Sample Report
Facial injectables Market Drivers and Restrains
Factors such as rising aesthetic consciousness and number of cosmetic procedures, introduction of cost-effective facial injectable and aging population are expected to drive the global Facial injectable Market during the forecast period. Moreover, changing market scenario in healthcare sector because of drug discovery & product launch is expected to fuel the global Facial injectables Market in forecast period. Strict regulatory concerns of injectable products and side effects of such products such as rashes and itching sensation are considered to be the major restraint to global Facial injectables Market.
Facial injectable Market key segmentation
By Type, Polymer fillers are further segmented into polymethylmethacrylate beads and poly-L-lactic acid. Collagen injectables are used for the treatment of wrinkles, laugh lines, creases, lip border restoration, facial rejuvenation, face contouring and acne scars. The collagen segment is anticipated to have favorable market growth over the forecast period because of the increasing use of collagen in facial injectables to correct facial skin imperfections. Dermatology clinics will witness significant growth opportunities over the period heading to increasing patient pool for facial treatments. Availability of skilled professionals specialized in dermal treatments such as fillers and injectable are responsible for this segmental growth.
Facial injectable Market Regional Analysis
North America was the most dominating market for facial injectables in 2021. Factors such as organized regulatory framework and reimbursement scenarios are further assisting the facial injectables market in North America and where responsible for this market growth. According to International Society of Aesthetic Plastic Surgery (ISAPS), U.S. holds the largest number of facial filling procedures carried out all over the world. Asia-Pacific is anticipated as the fastest growing market during the forecast period. Rising disposable income, awareness regarding aesthetic and plastic surgeries in the regions, especially in the countries such as India, South Korea and China are driving the facial injectables market in Asia-Pacific. Moreover, rapidly developing healthcare infrastructure and booming entertainment industry would further boost the growth of facial injectables market in Asia-Pacific.
The objective of the report is to present comprehensive analysis of Global Facial injectable Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Global Facial injectable Market dynamics, structure by analyzing the market segments, and project the Global Facial injectable Market size. Clear representation of competitive analysis of key players by Facial injectable Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Facial injectable Market make the report investor’s guide.
Scope of the Facial injectables Market: Inquire before buying
| Global Facial Injectables Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2021 | Forecast Period: | 2022-2029 |
| Historical Data: | 2017 to 2021 | Market Size in 2021: | US $ 4.88 Bn. |
| Forecast Period 2022 to 2029 CAGR: | 9.6% | Market Size in 2029: | US $ 10.17 Bn. |
| Segments Covered: | by Treatment | • Facial Pain • Wrinkle Treatment • Acne scar treatment • Lip Augmentation • Lipoatrophy treatment • Others |
|
| by Type | • Collagen • Hyaluronic Acid (HA) • Botulin Toxin Type A • Calcium Hydroxyapatite (Catha) • Polymer Fillers |
||
| by End User | • Hospitals • Ambulatory Surgical Centers • Cosmetic Centers • Dermatology Clinics • Physician Clinics |
||
Facial injectable Market by Region
• Asia Pacific
• North America
• Europe
• Latin America
• Middle East Africa
Key players operating on Facial injectable Market
• Bloomage BioTechnology Corporation Limited,
• Ipsen Group,
• Allergan Plc,
• Prollenium Medical Technologies Inc.,
• Galderma S.A. (Nestle), and
• Merz Pharma & Co. KGaA.
• Advanced Dermatology
• ColBar LifeScience Ltd., ,
• Valeant Pharmaceuticals North America LLC,
• Sano Biosurgery Inc.,
• Anika Therapeutics, Inc.
• Bausch Health Companies Inc.
• Sanofi
• Integra LifeSciences Corporation.
• Sinclair Pharma
• Suneva Medical.
• Scivision Biotech Inc.
• Zimmer Biomet
• Teoxane
• Merck Sharp & Dohme Corp.
• ColBar LifeScience Ltd.
• APTOS LTD
Frequently Asked Questions:
1. Which region has the largest share in Global Facial injectables Market?
Ans: Asia Pacific region holds the highest share in 2021.
2. What is the growth rate of Global Facial injectables Market?
Ans: The Global Facial injectable Market is growing at a CAGR of 9.6% during forecasting period 2022-2029.
3. What is scope of the Global Facial injectables Market report?
Ans: Global Facial injectable Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. What is the study period of this market?
Ans: The Global Facial injectable Market is studied from 2021 to 2029.
Table of Contents
Global Facial injectables Market
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Facial injectables Market Size, by Market Value (US$ Bn)
4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends and Emerging Technologies
5. Supply Side and Demand Side Indicators
6. Global Facial injectables Market Analysis and Forecast
6.1. Global Facial injectables Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America
7. Global Facial injectables Market Analysis and Forecast, by Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Facial injectables Market Value Share Analysis, by Type
7.4. Global Facial injectables Market Size (US$ Bn) Forecast, by Type
7.5. Global Facial injectables Market Analysis, by Type
7.6. Global Facial injectables Market Attractiveness Analysis, by Type
8. Global Facial injectables Market Analysis and Forecast, by Treatment
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Facial injectables Market Value Share Analysis, by Treatment
8.4. Global Facial injectables Market Size (US$ Bn) Forecast, by Treatment
8.5. Global Facial injectables Market Analysis, by Treatment
8.6. Global Facial injectables Market Attractiveness Analysis, by Treatment
9. Global Facial injectables Market Analysis and Forecast, by End-use
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Facial injectables Market Value Share Analysis, by End-use
9.4. Global Facial injectables Market Size (US$ Bn) Forecast, by End-use
9.5. Global Facial injectables Market Analysis, by End-use
9.6. Global Facial injectables Market Attractiveness Analysis, by End-use
10. Global Facial injectables Market Analysis, by Region
10.1. Global Facial injectables Market Value Share Analysis, by Region
10.2. Global Facial injectables Market Size (US$ Bn) Forecast, by Region
10.3. Global Facial injectables Market Attractiveness Analysis, by Region
11. North America Facial injectables Market Analysis
11.1. Key Findings
11.2. North America Facial injectables Market Overview
11.3. North America Facial injectables Market Value Share Analysis, by Type
11.4. North America Facial injectables Market Forecast, by Type
11.4.1. Collagen
11.4.2. Hyaluronic Acid (HA)
11.4.3. Botulinum Toxin Type A
11.4.4. Calcium Hydroxylapatite (CaHA)
11.4.5. Polymer Fillers
11.5. North America Facial injectables Market Value Share Analysis, by Treatment
11.6. North America Facial injectables Market Forecast, by Treatment
11.6.1. Facial Pain
11.6.2. Wrinkle Treatment
11.6.3. Acne scar treatment
11.6.4. Lip Augmentation
11.6.5. Lipoatrophy treatment
11.6.6. Others (chin augmentation and Earlobe rejuvenation)
11.7. North America Facial injectables Market Value Share Analysis, by End-use
11.8. North America Facial injectables Market Forecast, by End-use
11.8.1. Hospitals,
11.8.2. Ambulatory Surgical Centers,
11.8.3. Cosmetic Centers,
11.8.4. Dermatology Clinics,
11.8.5. Physician Clinic
11.9. North America Facial injectables Market Value Share Analysis, by Country
11.10. North America Facial injectables Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Facial injectables Market Analysis, by Country
11.12. U.S. Facial injectables Market Forecast, by Type
11.12.1. Collagen
11.12.2. Hyaluronic Acid (HA)
11.12.3. Botulinum Toxin Type A
11.12.4. Calcium Hydroxylapatite (CaHA)
11.12.5. Polymer Fillers
11.13. U.S. Facial injectables Market Forecast, by Treatment
11.13.1. Facial Pain
11.13.2. Wrinkle Treatment
11.13.3. Acne scar treatment
11.13.4. Lip Augmentation
11.13.5. Lipoatrophy treatment
11.13.6. Others (chin augmentation and Earlobe rejuvenation)
11.14. U.S. Facial injectables Market Forecast, by End-use
11.14.1. Hospitals,
11.14.2. Ambulatory Surgical Centers,
11.14.3. Cosmetic Centers,
11.14.4. Dermatology Clinics,
11.14.5. Physician Clinics
11.15. Canada Facial injectables Market Forecast, by Type
11.15.1. Collagen
11.15.2. Hyaluronic Acid (HA)
11.15.3. Botulinum Toxin Type A
11.15.4. Calcium Hydroxylapatite (CaHA)
11.15.5. Polymer Fillers
11.16. Steel Canada Facial injectables Market Forecast, by Treatment
11.16.1. Facial Pain
11.16.2. Wrinkle Treatment
11.16.3. Acne scar treatment
11.16.4. Lip Augmentation
11.16.5. Lipoatrophy treatment
11.16.6. Others (chin augmentation and Earlobe rejuvenation)
11.17. Canada Facial injectables Market Forecast, by End-use
11.17.1. Hospitals,
11.17.2. Ambulatory Surgical Centers,
11.17.3. Cosmetic Centers,
11.17.4. Dermatology Clinics,
11.17.5. Physician Clinics
11.18. North America Facial injectables Market Attractiveness Analysis
11.18.1. By Type
11.18.2. By Treatment
11.18.3. By End-use
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Developments
12. Europe Facial injectables Market Analysis
12.1. Key Findings
12.2. Europe Facial injectables Market Overview
12.3. Europe Facial injectables Market Value Share Analysis, by Type
12.4. Europe Facial injectables Market Forecast, by Type
12.4.1. Collagen
12.4.2. Hyaluronic Acid (HA)
12.4.3. Botulinum Toxin Type A
12.4.4. Calcium Hydroxylapatite (CaHA)
12.4.5. Polymer Fillers
12.5. Europe Facial injectables Market Value Share Analysis, by Treatment
12.6. Europe Facial injectables Market Forecast, by Treatment
12.6.1. Facial Pain,
12.6.2. Wrinkle Treatment,
12.6.3. Lip Augmentation
12.7. Europe Facial injectables Market Value Share Analysis, by End-use
12.8. Europe Facial injectables Market Forecast, by End-use
12.8.1. Hospitals,
12.8.2. Ambulatory Surgical Centers,
12.8.3. Cosmetic Centers,
12.8.4. Dermatology Clinics,
12.8.5. Physician Clinics
12.9. Europe Facial injectables Market Value Share Analysis, by Country
12.10. Europe Facial injectables Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Facial injectables Market Analysis, by Country
12.12. Germany Facial injectables Market Forecast, by Type
12.12.1. Collagen
12.12.2. Hyaluronic Acid (HA)
12.12.3. Botulinum Toxin Type A
12.12.4. Calcium Hydroxylapatite (CaHA)
12.12.5. Polymer Fillers
12.13. Germany Facial injectables Market Forecast, by Treatment
12.13.1. Facial Pain,
12.13.2. Wrinkle Treatment,
12.13.3. Lip Augmentation Facial Pain
12.13.4. Wrinkle Treatment
12.13.5. Acne scar treatment
12.13.6. Lip Augmentation
12.13.7. Lipoatrophy treatment
12.13.8. Others (chin augmentation and Earlobe rejuvenation)
12.14. Germany Facial injectables Market Forecast, by End-use
12.14.1. Hospitals,
12.14.2. Ambulatory Surgical Centers,
12.14.3. Cosmetic Centers,
12.14.4. Dermatology Clinics,
12.14.5. Physician Clinics
12.15. U.K. Facial injectables Market Forecast, by Type
12.15.1. Collagen
12.15.2. Hyaluronic Acid (HA)
12.15.3. Botulinum Toxin Type A
12.15.4. Calcium Hydroxylapatite (CaHA)
12.15.5. Polymer Fillers
12.16. U.K. Facial injectables Market Forecast, by Treatment
12.16.1. Facial Pain,
12.16.2. Wrinkle Treatment,
12.16.3. Lip Augmentation
12.17. U.K. Facial injectables Market Forecast, by End-use
12.17.1. Hospitals,
12.17.2. Ambulatory Surgical Centers,
12.17.3. Cosmetic Centers,
12.17.4. Dermatology Clinics,
12.17.5. Physician Clinics
12.18. France Facial injectables Market Forecast, by Type
12.18.1. Collagen
12.18.2. Hyaluronic Acid (HA)
12.18.3. Botulinum Toxin Type A
12.18.4. Calcium Hydroxylapatite (CaHA)
12.18.5. Polymer Fillers
12.19. France Facial injectables Market Forecast, by Treatment
12.19.1. Facial Pain
12.19.2. Wrinkle Treatment
12.19.3. Acne scar treatment
12.19.4. Lip Augmentation
12.19.5. Lipoatrophy treatment
12.19.6. Others (chin augmentation and Earlobe rejuvenation)
12.20. France Facial injectables Market Forecast, by End-use
12.20.1. Hospitals,
12.20.2. Ambulatory Surgical Centers,
12.20.3. Cosmetic Centers,
12.20.4. Dermatology Clinics,
12.20.5. Physician Clinics
12.21. Italy Facial injectables Market Forecast, by Type
12.21.1. Collagen
12.21.2. Hyaluronic Acid (HA)
12.21.3. Botulinum Toxin Type A
12.21.4. Calcium Hydroxylapatite (CaHA)
12.21.5. Polymer Fillers
12.22. Italy Facial injectables Market Forecast, by Treatment
12.22.1. Facial Pain
12.22.2. Wrinkle Treatment
12.22.3. Acne scar treatment
12.22.4. Lip Augmentation
12.22.5. Lipoatrophy treatment
12.22.6. Others (chin augmentation and Earlobe rejuvenation)
12.23. Italy Facial injectables Market Forecast, by End-use
12.23.1. Hospitals,
12.23.2. Ambulatory Surgical Centers,
12.23.3. Cosmetic Centers,
12.23.4. Dermatology Clinics,
12.23.5. Physician Clinics
12.24. Spain Facial injectables Market Forecast, by Type
12.24.1. Collagen
12.24.2. Hyaluronic Acid (HA)
12.24.3. Botulinum Toxin Type A
12.24.4. Calcium Hydroxylapatite (CaHA)
12.24.5. Polymer Fillers
12.25. Spain Facial injectables Market Forecast, by Treatment
12.25.1. Facial Pain
12.25.2. Wrinkle Treatment
12.25.3. Acne scar treatment
12.25.4. Lip Augmentation
12.25.5. Lipoatrophy treatment
12.25.6. Others (chin augmentation and Earlobe rejuvenation)
12.26. Spain Facial injectables Market Forecast, by End-use
12.26.1. Hospitals,
12.26.2. Ambulatory Surgical Centers,
12.26.3. Cosmetic Centers,
12.26.4. Dermatology Clinics,
12.26.5. Physician Clinics
12.27. Rest of Europe Facial injectables Market Forecast, by Type
12.27.1. Collagen
12.27.2. Hyaluronic Acid (HA)
12.27.3. Botulinum Toxin Type A
12.27.4. Calcium Hydroxylapatite (CaHA)
12.27.5. Polymer Fillers
12.28. Rest of Europe Facial injectables Market Forecast, by Treatment
12.28.1. Facial Pain
12.28.2. Wrinkle Treatment
12.28.3. Acne scar treatment
12.28.4. Lip Augmentation
12.28.5. Lipoatrophy treatment
12.28.6. Others (chin augmentation and Earlobe rejuvenation)
12.29. Rest Of Europe Facial injectables Market Forecast, by End-use
12.29.1. Hospitals,
12.29.2. Ambulatory Surgical Centers,
12.29.3. Cosmetic Centers,
12.29.4. Dermatology Clinics,
12.29.5. Physician Clinics
12.30. Europe Facial injectables Market Attractiveness Analysis
12.30.1. By Type
12.30.2. By Treatment
12.30.3. By End-use
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Developments
13. Asia Pacific Facial injectables Market Analysis
13.1. Key Findings
13.2. Asia Pacific Facial injectables Market Overview
13.3. Asia Pacific Facial injectables Market Value Share Analysis, by Type
13.4. Asia Pacific Facial injectables Market Forecast, by Type
13.4.1. Collagen
13.4.2. Hyaluronic Acid (HA)
13.4.3. Botulinum Toxin Type A
13.4.4. Calcium Hydroxylapatite (CaHA)
13.4.5. Polymer Fillers
13.5. Asia Pacific Facial injectables Market Value Share Analysis, by Treatment
13.6. Asia Pacific Facial injectables Market Forecast, by Treatment
13.6.1. Facial Pain
13.6.2. Wrinkle Treatment
13.6.3. Acne scar treatment
13.6.4. Lip Augmentation
13.6.5. Lipoatrophy treatment
13.6.6. Others (chin augmentation and Earlobe rejuvenation)
13.7. Asia Pacific Facial injectables Market Value Share Analysis, by End-use
13.8. Asia Pacific Facial injectables Market Forecast, by End-use
13.8.1. Hospitals,
13.8.2. Ambulatory Surgical Centers,
13.8.3. Cosmetic Centers,
13.8.4. Dermatology Clinics,
13.8.5. Physician Clinics
13.9. Asia Pacific Facial injectables Market Value Share Analysis, by Country
13.10. Asia Pacific Facial injectables Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Facial injectables Market Analysis, by Country
13.12. China Facial injectables Market Forecast, by Type
13.12.1. Collagen
13.12.2. Hyaluronic Acid (HA)
13.12.3. Botulinum Toxin Type A
13.12.4. Calcium Hydroxylapatite (CaHA)
13.12.5. Polymer Fillers
13.13. China Facial injectables Market Forecast, by Treatment
13.13.1. Facial Pain
13.13.2. Wrinkle Treatment
13.13.3. Acne scar treatment
13.13.4. Lip Augmentation
13.13.5. Lipoatrophy treatment
13.13.6. Others (chin augmentation and Earlobe rejuvenation)
13.14. China Facial injectables Market Forecast, by End-use
13.14.1. Hospitals,
13.14.2. Ambulatory Surgical Centers,
13.14.3. Cosmetic Centers,
13.14.4. Dermatology Clinics,
13.14.5. Physician Clinics
13.15. India Facial injectables Market Forecast, by Type
13.15.1. Collagen
13.15.2. Hyaluronic Acid (HA)
13.15.3. Botulinum Toxin Type A
13.15.4. Calcium Hydroxylapatite (CaHA)
13.15.5. Polymer Fillers
13.16. India Facial injectables Market Forecast, by Treatment
13.16.1. Facial Pain
13.16.2. Wrinkle Treatment
13.16.3. Acne scar treatment
13.16.4. Lip Augmentation
13.16.5. Lipoatrophy treatment
13.16.6. Others (chin augmentation and Earlobe rejuvenation)
13.17. India Facial injectables Market Forecast, by End-use
13.17.1. Hospitals,
13.17.2. Ambulatory Surgical Centers,
13.17.3. Cosmetic Centers,
13.17.4. Dermatology Clinics,
13.17.5. Physician Clinics
13.18. Japan Facial injectables Market Forecast, by Type
13.18.1. Collagen
13.18.2. Hyaluronic Acid (HA)
13.18.3. Botulinum Toxin Type A
13.18.4. Calcium Hydroxylapatite (CaHA)
13.18.5. Polymer Fillers
13.19. Japan Facial injectables Market Forecast, by Treatment
13.19.1. Facial Pain
13.19.2. Wrinkle Treatment
13.19.3. Acne scar treatment
13.19.4. Lip Augmentation
13.19.5. Lipoatrophy treatment
13.19.6. Others (chin augmentation and Earlobe rejuvenation)
13.20. Japan Facial injectables Market Forecast, by End-use
13.20.1. Hospitals,
13.20.2. Ambulatory Surgical Centers,
13.20.3. Cosmetic Centers,
13.20.4. Dermatology Clinics,
13.20.5. Physician Clinics
13.21. ASEAN Facial injectables Market Forecast, by Type
13.21.1. Collagen
13.21.2. Hyaluronic Acid (HA)
13.21.3. Botulinum Toxin Type A
13.21.4. Calcium Hydroxylapatite (CaHA)
13.21.5. Polymer Fillers
13.22. ASEAN Facial injectables Market Forecast, by Treatment
13.22.1. Facial Pain
13.22.2. Wrinkle Treatment
13.22.3. Acne scar treatment
13.22.4. Lip Augmentation
13.22.5. Lipoatrophy treatment
13.22.6. Others (chin augmentation and Earlobe rejuvenation)
13.23. ASEAN Facial injectables Market Forecast, by End-use
13.23.1. Hospitals,
13.23.2. Ambulatory Surgical Centers,
13.23.3. Cosmetic Centers,
13.23.4. Dermatology Clinics,
13.23.5. Physician Clinics
13.24. Rest of Asia Pacific Facial injectables Market Forecast, by Type
13.24.1. Collagen
13.24.2. Hyaluronic Acid (HA)
13.24.3. Botulinum Toxin Type A
13.24.4. Calcium Hydroxylapatite (CaHA)
13.24.5. Polymer Fillers
13.25. Rest of Asia Pacific Facial injectables Market Forecast, by Treatment
13.25.1. Facial Pain
13.25.2. Wrinkle Treatment
13.25.3. Acne scar treatment
13.25.4. Lip Augmentation
13.25.5. Lipoatrophy treatment
13.25.6. Others (chin augmentation and Earlobe rejuvenation)
13.26. Rest of Asia Pacific Facial injectables Market Forecast, by End-use
13.26.1. Hospitals,
13.26.2. Ambulatory Surgical Centers,
13.26.3. Cosmetic Centers,
13.26.4. Dermatology Clinics,
13.26.5. Physician Clinics
13.27. Asia Pacific Facial injectables Market Attractiveness Analysis
13.27.1. By Type
13.27.2. By Treatment
13.27.3. By End-use
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Developments
14. Middle East & Africa Facial injectables Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Facial injectables Market Overview
14.3. Middle East & Africa Facial injectables Market Value Share Analysis, by Type
14.4. Middle East & Africa Facial injectables Market Forecast, by Type
14.4.1. Collagen
14.4.2. Hyaluronic Acid (HA)
14.4.3. Botulinum Toxin Type A
14.4.4. Calcium Hydroxylapatite (CaHA)
14.4.5. Polymer Fillers
14.5. Middle East & Africa Facial injectables Market Value Share Analysis, by Treatment
14.6. Middle East & Africa Facial injectables Market Forecast, by Treatment
14.6.1. Facial Pain
14.6.2. Wrinkle Treatment
14.6.3. Acne scar treatment
14.6.4. Lip Augmentation
14.6.5. Lipoatrophy treatment
14.6.6. Others (chin augmentation and Earlobe rejuvenation)
14.7. Middle East & Africa Facial injectables Market Value Share Analysis, by End-use
14.8. Middle East & Africa Facial injectables Market Forecast, by End-use
14.8.1. Hospitals,
14.8.2. Ambulatory Surgical Centers,
14.8.3. Cosmetic Centers,
14.8.4. Dermatology Clinics,
14.8.5. Physician Clinics
14.9. Middle East & Africa Facial injectables Market Value Share Analysis, by Country
14.10. Middle East & Africa Facial injectables Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Facial injectables Market Analysis, by Country
14.12. GCC Facial injectables Market Forecast, by Type
14.12.1. Collagen
14.12.2. Hyaluronic Acid (HA)
14.12.3. Botulinum Toxin Type A
14.12.4. Calcium Hydroxylapatite (CaHA)
14.12.5. Polymer Fillers
14.13. GCC Facial injectables Market Forecast, by Treatment
14.13.1. Facial Pain
14.13.2. Wrinkle Treatment
14.13.3. Acne scar treatment
14.13.4. Lip Augmentation
14.13.5. Lipoatrophy treatment
14.13.6. Others (chin augmentation and Earlobe rejuvenation)
14.14. GCC Facial injectables Market Forecast, by End-use
14.14.1. Hospitals,
14.14.2. Ambulatory Surgical Centers,
14.14.3. Cosmetic Centers,
14.14.4. Dermatology Clinics,
14.14.5. Physician Clinics
14.15. South Africa Facial injectables Market Forecast, by Type
14.15.1. Collagen
14.15.2. Hyaluronic Acid (HA)
14.15.3. Botulinum Toxin Type A
14.15.4. Calcium Hydroxylapatite (CaHA)
14.15.5. Polymer Fillers
14.16. South Africa Facial injectables Market Forecast, by Treatment
14.16.1. Facial Pain
14.16.2. Wrinkle Treatment
14.16.3. Acne scar treatment
14.16.4. Lip Augmentation
14.16.5. Lipoatrophy treatment
14.16.6. Others (chin augmentation and Earlobe rejuvenation)
14.17. South Africa Facial injectables Market Forecast, by End-use
14.17.1. Hospitals,
14.17.2. Ambulatory Surgical Centers,
14.17.3. Cosmetic Centers,
14.17.4. Dermatology Clinics,
14.17.5. Physician Clinics
14.18. Rest of Middle East & Africa Facial injectables Market Forecast, by Type
14.18.1. Collagen
14.18.2. Hyaluronic Acid (HA)
14.18.3. Botulinum Toxin Type A
14.18.4. Calcium Hydroxylapatite (CaHA)
14.18.5. Polymer Fillers
14.19. Rest of Middle East & Africa Facial injectables Market Forecast, by Treatment
14.19.1. Facial Pain
14.19.2. Wrinkle Treatment
14.19.3. Acne scar treatment
14.19.4. Lip Augmentation
14.19.5. Lipoatrophy treatment
14.19.6. Others (chin augmentation and Earlobe rejuvenation)
14.20. Rest of Middle East & Africa Facial injectables Market Forecast, by End-use
14.20.1. Hospitals,
14.20.2. Ambulatory Surgical Centers,
14.20.3. Cosmetic Centers,
14.20.4. Dermatology Clinics,
14.20.5. Physician Clinics
14.21. Middle East & Africa Facial injectables Market Attractiveness Analysis
14.21.1. By Type
14.21.2. By Treatment
14.21.3. By End-use
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Developments
15. South America Facial injectables Market Analysis
15.1. Key Findings
15.2. South America Facial injectables Market Overview
15.3. South America Facial injectables Market Value Share Analysis, by Type
15.4. South America Facial injectables Market Forecast, by Type
15.4.1. Collagen
15.4.2. Hyaluronic Acid (HA)
15.4.3. Botulinum Toxin Type A
15.4.4. Calcium Hydroxylapatite (CaHA)
15.4.5. Polymer Fillers
15.5. South America Facial injectables Market Value Share Analysis, by Treatment
15.6. South America Facial injectables Market Forecast, by Treatment
15.6.1. Facial Pain
15.6.2. Wrinkle Treatment
15.6.3. Acne scar treatment
15.6.4. Lip Augmentation
15.6.5. Lipoatrophy treatment
15.6.6. Others (chin augmentation and Earlobe rejuvenation)
15.7. South America Facial injectables Market Value Share Analysis, by End-use
15.8. South America Facial injectables Market Forecast, by End-use
15.8.1. Hospitals,
15.8.2. Ambulatory Surgical Centers,
15.8.3. Cosmetic Centers,
15.8.4. Dermatology Clinics,
15.8.5. Physician Clinics
15.9. South America Facial injectables Market Value Share Analysis, by Country
15.10. South America Facial injectables Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Facial injectables Market Analysis, by Country
15.12. Brazil Facial injectables Market Forecast, by Type
15.12.1. Collagen
15.12.2. Hyaluronic Acid (HA)
15.12.3. Botulinum Toxin Type A
15.12.4. Calcium Hydroxylapatite (CaHA)
15.12.5. Polymer Fillers
15.13. Brazil Facial injectables Market Forecast, by Treatment
15.13.1. Facial Pain
15.13.2. Wrinkle Treatment
15.13.3. Acne scar treatment
15.13.4. Lip Augmentation
15.13.5. Lipoatrophy treatment
15.13.6. Others (chin augmentation and Earlobe rejuvenation)
15.14. Brazil Facial injectables Market Forecast, by End-use
15.14.1. Hospitals,
15.14.2. Ambulatory Surgical Centers,
15.14.3. Cosmetic Centers,
15.14.4. Dermatology Clinics,
15.14.5. Physician Clinics
15.15. Mexico Facial injectables Market Forecast, by Type
15.15.1. Collagen
15.15.2. Hyaluronic Acid (HA)
15.15.3. Botulinum Toxin Type A
15.15.4. Calcium Hydroxylapatite (CaHA)
15.15.5. Polymer Fillers
15.16. Mexico Facial injectables Market Forecast, by Treatment
15.16.1. Facial Pain
15.16.2. Wrinkle Treatment
15.16.3. Acne scar treatment
15.16.4. Lip Augmentation
15.16.5. Lipoatrophy treatment
15.16.6. Others (chin augmentation and Earlobe rejuvenation)
15.17. Mexico Market Forecast, by End-use
15.17.1. Hospitals,
15.17.2. Ambulatory Surgical Centers,
15.17.3. Cosmetic Centers,
15.17.4. Dermatology Clinics,
15.17.5. Physician Clinics
15.18. Rest of South America Facial injectables Market Forecast, by Type
15.18.1. Collagen
15.18.2. Hyaluronic Acid (HA)
15.18.3. Botulinum Toxin Type A
15.18.4. Calcium Hydroxylapatite (CaHA)
15.18.5. Polymer Fillers
15.19. Rest of South America Facial injectables Market Forecast, by Treatment
15.19.1. Facial Pain
15.19.2. Wrinkle Treatment
15.19.3. Acne scar treatment
15.19.4. Lip Augmentation
15.19.5. Lipoatrophy treatment
15.19.6. Others (chin augmentation and Earlobe rejuvenation)d
15.20. Rest of South America Facial injectables Market Forecast, by End-use
15.20.1. Hospitals,
15.20.2. Ambulatory Surgical Centers,
15.20.3. Cosmetic Centers,
15.20.4. Dermatology Clinics,
15.20.5. Physician Clinics
15.21. South America Facial injectables Market Attractiveness Analysis
15.21.1. By Type
15.21.2. By Treatment
15.21.3. By End-use
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Developments
16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
16.3. Company Profiles: Key Players
16.3.1. Bloomage BioTechnology Corporation Limited
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Development Footprint
16.3.2. Ipsen Group,
16.3.3. Allergan Plc,
16.3.4. Prollenium Medical Technologies Inc.,
16.3.5. Galderma S.A. (Nestle), and
16.3.6. Merz Pharma & Co. KGaA.
16.3.7. Advanced Dermatology
16.3.8. ColBar LifeScience Ltd., ,
16.3.9. Valeant Pharmaceuticals North America LLC,
16.3.10. Sano Biosurgery Inc.,
16.3.11. Anika Therapeutics, Inc.
16.3.12. Suneva Medical, Inc
16.3.13. Ipsen
16.3.14. Integra Lifesciences
16.3.15. Tei Biosciences
16.3.16. Fibrogen
16.3.17. Ethicon
17. Primary Key Insights